We propose the development of an interdisciplinary training program to prepare bioengineers for careers as independent researchers in diabetes. The long-term goal of this program is to foster the career development of biomedical engineers in interdisciplinary research related to diabetes. This program will build on Yale's considerable experience in the training of biomedical engineers, which will be coupled with world-leading programs in diabetes research. This application requests postdoctoral stipends for five postdoctoral (MD, PhD, or MD/PhD) fellows per year. This request is based on several factors: 1) The ongoing critical need for bioengineering scientists dedicated to studying diabetes. 2) The expanded opportunities afforded by our interdisciplinary training faculty. 3) The increase in the number of medical residents with engineering backgrounds. 4) The high quality of biomedical engineers applying to Yale postdoctoral programs. Our experience in interdisciplinary training indicates that three or more years of research training are needed for fellows to develop the skills needed for independent research. We believe a program specifically dedicated to introducing engineers to cutting-edge, interdisciplinary research in diabetes will lead to the development of scientists ready to build impactful research programs in diabetes. This program will have several key components: (1) Recruitment of bioengineering postdoctoral fellows with interests in diabetes. (2) Matching fellows with superb research mentors. (3) Participation of fellows in research projects with co-mentors in bioengineering and diabetes research. (4) Participation in a core didactic research curriculum. (5) Critical and rigorous scholar and program evaluation. (6) Establishment of a career guidance program. While enrolled in the program, postdoctoral fellows will have 80% of their time specifically dedicated to research, and support will be provided for 3 years. The focus of this program will be on bioengineering training, which has been identified as an area where diabetes scientists are greatly needed. To achieve these goals, we will take advantage of several established programs at Yale specifically designed for training in diabetes. Potential mentors have good NIH support and a proven record of training fellows in diabetes or biomedical engineering. Please see the required T32-related supporting tables. Table 1 lists participating departments;Table 2 lists mentors and rank;Table 3 lists mentor department training programs;Table 4 lists mentor grant support;Table 5 lists mentor trainees over the past 10 years;Table 8 lists post- doctoral applicants for fellowships over the past 5 years. It is anticipated that this program will lead to the training of exceptional bioengineers, who will embark on promising careers focusing on interdisciplinary diabetes research.
We propose the development of an interdisciplinary bioengineering training program in the Department of Biomedical Engineering at Yale University. The long-term goal of this program is to foster the career development of biomedical engineers in interdisciplinary research related to diabetes. This program will build on our considerable experience and expertise in training of biomedical engineers, and our considerable resources in diabetes research. It is anticipated that this program will lead to the training of exceptional bioengineers who will embark on promising careers focusing on interdisciplinary diabetes research.
|Perry, Rachel J; Petersen, Kitt Falk; Shulman, Gerald I (2016) Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis. Diabetologia 59:933-7|
|Perry, Rachel J; Borders, Candace B; Cline, Gary W et al. (2016) Propionate Increases Hepatic Pyruvate Cycling and Anaplerosis and Alters Mitochondrial Metabolism. J Biol Chem 291:12161-70|
|Perry, Rachel J; Peng, Liang; Barry, Natasha A et al. (2016) Acetate mediates a microbiome-brain-Î²-cell axis to promote metabolic syndrome. Nature 534:213-7|
|Pesta, Dominik H; Perry, Rachel J; Guebre-Egziabher, Fitsum et al. (2015) Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5). Aging (Albany NY) 7:1086-93|
|Vatner, Daniel F; Snikeris, Jaclyn; Popov, Violeta et al. (2015) 3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats. PLoS One 10:e0140837|
|Perry, Rachel J; Lee, Sangwon; Ma, Lie et al. (2015) FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Commun 6:6980|
|Perry, Rachel J; Camporez, JoÃ£o-Paulo G; Kursawe, Romy et al. (2015) Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160:745-58|
|Perry, Rachel J; Zhang, Dongyan; Zhang, Xian-Man et al. (2015) Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 347:1253-6|
|NeuschÃ¤fer-Rube, Frank; Lieske, Stefanie; Kuna, Manuela et al. (2014) The mammalian INDY homolog is induced by CREB in a rat model of type 2 diabetes. Diabetes 63:1048-57|
|Rahimi, Yasmeen; Camporez, JoÃ£o-Paulo G; Petersen, Max C et al. (2014) Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance. Proc Natl Acad Sci U S A 111:16508-13|
Showing the most recent 10 out of 15 publications